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Diastolic function of the right ventricle is impaired in experimental
type 2 diabetic rat models
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Aim: To evaluate diastolic function alterations of the right ventricle (RV) by echocardiography in type 2 diabetic rat models.
Materials and methods: Male Wistar rats were divided into 2 groups: a control group (n = 8) and a diabetic group (n = 16, with 11
remaining at the end of the experiment), which was fed a high-fat and high-calorie diet and injected with streptozotocin (STZ). RV
diastolic functional alteration of rat models was studied by the tricuspid flow Doppler (Ep, Ap, and Ep/Ap) and tissue Doppler imaging
(TDI) (Em, Am, and Em/Am) of the lateral tricuspid annulus. RV structural alteration of rat models was studied by standard 2D and
M-mode echocardiography.
Results: Compared with the control group rats, at the 12th week after STZ injection, the rats of the diabetic group developed RV
diastolic dysfunction, lower Em, and lower ratios (Ep/Ap, Em/Am). At the end of the experiment, at the 16th week after STZ injection,
the rats of the diabetic group showed further decreased Ep, Em, and ratios (Ep/Ap, Em/Am) and significantly higher RV diameters
compared with the control group rats.
Conclusion: We demonstrated that the diastolic dysfunction of the RV was the earliest complication observed in type 2 diabetic rat
models, using TDI and tricuspid flow Doppler. TDI showed a high sensitivity in detecting changes of RV diastolic function.
Key words: Right ventricle, diastolic function, diabetic cardiomyopathy, echocardiography, rats

1. Introduction
Diabetes-induced myocardial diseases are the primary
causes of morbidity and mortality in patients with diabetes
mellitus (DM) (1). In 1972, Rubler et al. described a
special type of diabetes-induced myocardial disease as
the development of heart failure in diabetic subjects
with the absence of ischemic, hypertension, and valvular
heart disease, which was called diabetic cardiomyopathy
(DCM) (2). The existence of DCM has been confirmed
as evidence for the presence of myocardial dysfunction
in diabetic patients without other heart diseases. Fang
et al. reported that diabetic patients without overt heart
disease demonstrate evidence of systolic dysfunction
and increased myocardial reflectivity (3), which was in
accordance with other studies in diabetic patients (4,5).
The findings of myocardial impairment are similar in type
1 and type 2 diabetes mellitus (5,6). In animal experiments,
Kim et al. described increased heart indexes and impaired
mitral annulus velocity in diabetic rats (7).
* Correspondence: nning-my@163.com
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As far as cardiac change of diabetic subjects is
concerned, the left ventricle (LV) is generally paid more
attention. Some recent findings indicated that myocardial
damage in patients with diabetes affects diastolic
dysfunction before systolic function, and it will be more
significant for early diagnosis in order evaluate the
outcomes of preclinical diastolic dysfunction in diabetic
patients (8,9). Although it has been underestimated in the
past, the contribution of the right ventricle (RV) function to
overall myocardial contractility is considerable. However,
relatively limited data exist for RV changes in the diabetic
population, identified via noninvasive echocardiography,
especially for RV diastolic function. The purpose of the
present study is to assess RV structural and functional
alteration, and especially RV diastolic function, by using
echocardiography, including standard 2D, M-mode,
conventional Doppler, and tissue Doppler imaging (TDI)
echocardiography, in fat-fed, streptozotocin (STZ)induced type 2 diabetic rat models.
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2. Methods
2.1. Animal procedures
Male Wistar rats (weighing 180–220 g) were obtained from
the Animal Center of the Shandong University (Jinan,
China) and were randomly divided into the control group
(n = 8) or the diabetic group (n = 16). Diabetic group rats
were fed a high-fat and high-calorie diet (total 20 KJ/g
and 25% fat), and after 5 weeks, they were injected with
a single dose of STZ (30 mg/kg). Control group rats were
fed a standard chow diet consisting of a total of 14 KJ/g
and 8% fat. Details of the type 2 diabetic rat model process
were published in our previous study (10).
Fasting blood glucose (FBG) was measured by glucose
oxidase method in an automatic biochemical analyzer
(DVI 1650), and fasting insulin (FINS) was measured
with a radioimmunoassay (RIA) kit (BNIBT Co, China)
in a RIA counter (XH-6010). The standard for diabetic
rats was FBG ≥ 11.1 mmol/L in 2 consecutive analyses,
and the insulin sensitivity index [ISI = ln (FBG ×
FINS)–1] was lower than that of the control group. Rats
were subsequently maintained for 16 weeks. The study
conformed to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health.
2.2. Echocardiography
Rats were anesthetized with chloral hydrate (30 mg/kg).
Their chests were shaved, and echocardiography was
performed on each rat at baseline, at the 12th week after
STZ or buffer injection, and at the end of the experiment
(16th week after STZ or buffer injection) using a standard
commercial ultrasound machine (HP SONOS 7500;
Hewlett-Packard, USA) with a 5–12 MHz transducer.
Meanwhile, the 3-lead electrocardiogram was recorded
from the front limbs and the right hind limb. Standard
2D, 2D-guided M-mode, pulsed-wave Doppler, and TDI
echocardiography were performed on all rats by a single
experienced operator blinded to different groups. All
images were saved in magneto optical disks for offline
analysis. All of the parameters were averaged by at least 3
consecutive cardiac cycles.
2.3. Standard 2D and M-mode echocardiographic
measurements
Standard 2D images of each rat were obtained via the
parasternal long and short axis views and the apical
4-chamber view, and 2D-guided M-mode images were
obtained via the parasternal long axis view. The right
cardiac end-diastolic diameters, including RV diameter
(RVD), right atrium left-to-right diameter (RADlr), and
right atrium anterior-to-posterior diameter (RADap),
were measured from the standard 2D images. The enddiastolic wall thickness, including interventricular septum
(IVS) and RV free wall thickness (RVFW), were obtained
by M-mode.

2.4. Conventional Doppler measurements
The same ultrasound machine was used to acquire the
pulsed-wave Doppler spectra of the tricuspid inflow. The
sample volume was placed between the tips of tricuspid
leaflets in the apical 4-chamber view. The Doppler beam was
aligned parallel to flow direction to obtain the maximum
velocity, which was identified on a color Doppler image.
The peak early transtricuspid filling velocity (Ep), peak
transtricuspid atrial filling velocity during late diastole
(Ap), and their ratio (Ep/Ap) were measured to evaluate
the right ventricular function. Measurements were
averaged from 3 end-expiratory cycles.
2.5. Tissue Doppler measurements
Lateral tricuspid annular tissue Doppler velocities were
recorded by pulsed-wave TDI in the apical 4-chamber
views. Using the same probe with low filter and gain
settings, the smallest sample volume was placed at the
lateral corner of the tricuspid annulus. Signals were
obtained from 3 end-expiratory cycles, and averages were
made for the systolic and diastolic velocities. Pulse-wave
TDI results of the tricuspid annulus were characterized
by 1 myocardial systolic wave (systolic maximal velocity,
Sm) and 2 diastolic waves, early-diastolic maximal velocity
(Em) and atrial-contraction maximal velocity (Am), and
their ratio (Em/Am).
2.6. Statistical Analysis
SPSS 18.0 was used in our study. All values are expressed
as mean ± SD. Unpaired Student’s t-tests were used to
compare variable differences between the 2 groups. Results
were considered statistically significant if P < 0.05.
3. Results
3.1. The differences of FBG and ISI in control group and
diabetic group
In the diabetic group, 3 rats died from ketosis, infection, or
other diabetic complications and 2 rats failed to meet the
diagnostic criteria of diabetes. There were 11 rats in the
diabetic group and 8 rats in the control group at the end of
the experiment.
There were no significant differences in FBG and ISI
between the 2 groups (Figures 1a and 1b). Diabetic group
rats, which were fed a 4-week high-calorie diet, showed
low ISI compared to the control group rats, which showed
a higher insulin resistance. The difference of ISI between
the 2 groups remained until the end of the experiment. As
expected, the diabetic group rats had higher levels of FBG
than the control group rats from the fifth week after STZ
injection until the end of the experiment.
3.2. RV structural changes in the control group and the
diabetic group
RV structural changes were measured by standard 2D and
M-mode echocardiography and are summarized in Table
1. At the 12th week after STZ or buffer injection, there was
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Figure 1. FBG (a) and ISI (b) in the control group and the diabetic group. FBG = Fasting blood glucose; ISI = insulin sensitivity index;
n = 8 for control group; n = 11 for diabetic group.
Table 1. RV structural changes in the control group and the diabetic group. STZ = streptozotocin; RADap = right atrium anterior-toposterior diameter; RADlr = right atrium left-to-right diameter; RVD = right ventricular diameters; IVS = interventricular septum;
RVFW = right ventricular free wall thickness; n = 8 for control group; n = 11 for diabetic group.

At the 12th week
At the end of the
experiment

RADap (mm)

RADlr (mm)

RVD (mm)

IVS (mm)

RVFW (mm)

Control group

4.39 ± 1.12

4.58 ± 1.23

2.90 ± 0.43

1.69 ± 0.24

0.61 ± 0.11

Diabetic group

4.56 ± 1.19

4.85 ± 1.02

3.02 ± 0.66

1.75 ± 0.29

0.63 ± 0.17

Control group

4.42 ± 1.17

4.61 ± 1.40

2.97 ± 0.19

1.74 ± 0.16

0.63 ± 0.10

Diabetic group

4.66 ± 1.09

5.07 ± 0.41

3.25 ± 0.25*

1.84 ± 0.19

0.66 ± 0.12

no significant difference in any structural indices of RV
in the 2 groups. At the end of the experiment, although
the measurements of RADap, RADlr, IVS, and RVFW
were greater in the diabetic group than in the control
group, these findings did not reach statistical significance.
However, by comparison with the control group, the
diabetic group showed significantly higher RVD (P < 0.05).
3.3. RV diastolic function in the control group and the
diabetic group
The RV diastolic function was evaluated by conventional
flow Doppler (Figure 2a) and TDI (Figure 2b). The results
of the 2 groups are shown in Table 2, which includes the
diastolic function parameters Ep, Em, and their ratios (Ep/
Ap, Em/Am), and systolic function parameters (Sm). At
the 12th week after the STZ or buffer injection, the Ep/
Ap of the tricuspid flow Doppler in the diabetic group and
the Em and Em/Am of TDI were lower than those of the
control group. At the end of the experiment, according to
the flow Doppler, the tricuspid Ep was significantly lower
in the diabetic group, with consequently significantly lower
Ep/Ap. The TDI of tricuspid annulus showed that Em and
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Em/Am in the diabetic group were lower than those in the
control group. Sm and Am in the 2 groups were similar.
It can be concluded that the RV diastolic dysfunction was
visible in the type 2 diabetic rats.
4. Discussion
To understand diabetic cardiac dysfunction, we
developed a rat model of type 2 diabetes. Type 2 diabetes
is characterized by reduced insulin sensitivity (insulin
resistance) and higher blood glucose. In the present
experiment, insulin resistance was induced by a high-fat
diet initially (11). Thereafter, a low-dose STZ injection
slightly reduced the number of β cells, which eventually
resulted in hyperglycemia (12). The rat strain well
resembled the natural history and metabolic characteristics
of human type 2 diabetes.
The detection of subclinical cardiac dysfunction in
diabetic patients may provide an approach for identifying
high-risk individuals who may benefit from earlier
and more active intervention to prevent heart failure.
Subclinical cardiac dysfunction is common in patients
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Figure 2. Tricuspid inflow Doppler (a) and TDI (b) of tricuspid annulus in rats.

Table 2. RV diastolic function in the control group and the diabetic group. STZ = streptozotocin; TDI = tissue Doppler imaging; Ep =
the peak early transtricuspid filling velocity; Ap = peak transtricuspid atrial filling velocity during late diastole; Ep/Ap = the ratio of Ep
and Ap; Em = early-diastolic maximal velocity; Am = atrial-contraction maximal velocity; Em/Am = the ratio of Em and Am; Sm =
systolic maximal velocity; n = 8 for control group; n = 11 for diabetic group; * = P < 0.05; ** = P < 0.01.
Tricuspid inflow Doppler

At the 12th
week
At the end of
the experiment

TDI

Ep (cm/s)

Ap (cm/s)

Ep/Ap

Control group

81.61 ± 18.12

38.40 ± 7.88

2.14 ± 0.29

6.42 ± 1.18

Diabetic group

72.06 ± 14.01

42.38 ± 5.81

1.71 ± 0.34

Control group

84.11 ± 12.12

39.15 ± 6.09

Diabetic group

70.25 ± 12.79**

43.37 ± 6.07

with diabetes, and in these studies, some reported that
cardiac diastolic dysfunction represents an early stage of
myocardial damage in patients with diabetes, without any
clinical manifestations (8,9). Although RV dysfunction
has not been paid due attention in the past, in recent years,
researchers have gradually realized that RV dysfunction
is relevant and is an independent predictor in a variety of
disease states (13,14). Van den Brom reported RV systolic
dysfunction in Zucker diabetic fatty rats (15). Several
clinical studies using echocardiography have also shown
RV dysfunction in patients with diabetes (16,17). However,
in the above studies, the alteration of RV diastolic function,
which should be paid more attention, was not studied. In
the present study, we detected the changes of RV function,
especially RV diastolic function, in type 2 diabetic rats
using pulsed wave Doppler and TDI.
During the early stages of cardiac metabolic
impairments, the heart goes through a phase of
adjustment to the newly appearing metabolic disorders,
and the normal myocardial structure and architecture,

Em (cm/s)

Am (cm/s)

Em/Am

4.30 ± 0.80

1.51 ± 0.24

5.61 ± 1.01

4.51 ± 1.30

4.82 ± 0.25

0.94 ± 0.29

5.04 ± 1.18

2.21 ± 0.56

6.30 ± 0.93

4.37 ± 0.92

1.49 ± 0.34

5.83 ± 1.28

1.58 ± 0.38**

4.17 ± 1.28**

5.41 ± 1.25

0.81 ± 0.33**

4.81 ± 1.34

*

*

Sm (cm/s)

**

such as the wall thickness and the internal dimensions
of cardiac cavities, are maintained. However, lesions
occurring at a myocytic level are functionally expressed
and can be detected with modern echocardiographic
techniques. At the 12th week after STZ injection, this
study showed that the tricuspid Ep/Ap ratio decreased
in diabetic rats. The TDI of tricuspid annulus showed
that Em and Em/Am in the diabetic group were lower
than those in the control group. However, there were no
significant differences of RV wall thickness and internal
dimensions in the 2 groups at the 12th week after the STZ
injection. Karamitsos et al. described a similar finding
by demonstrating RV dysfunction prior to the structural
abnormality in type 1 diabetic patients (18). However, as
the experiment continued, the changes in the structure of
the myocardium became visible. At the end of the current
experiment, at the 16th week after STZ injection, diabetic
rats showed significantly higher RVD compared to control
rats. However, the other measurements of the right cardiac
structure still failed to reach statistical significance.
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As we mentioned above, at the 12th week after STZ
injection, RV diastolic dysfunction could be found by
echocardiography. At the 16th week after STZ injection,
the diabetic rats showed more deteriorated RV functions,
characterized by decreased Ep, Em, and their ratios (Ep/
Ap, Em/Am), which reflected impaired diastolic function
of the RV. TDI can confirm the presence of diastolic
dysfunctions, as well as systolic dysfunction: Em and Em/
Am are for RV diastolic function and Sm is for the RV
systolic function. In our study, we did not find evidence
of any significant difference in Sm between the 2 groups
throughout the whole experiment. This result was in
accordance with the report by Karamitsos et al. (18).
Furthermore, in the present study, TDI of tricuspid
annulus showed higher sensitivity in detection of RV
diastolic function than the conventional flow Doppler of
tricuspid annulus. As far as TDI was concerned, in addition
to the ratio of Em/Am, Em showed visible differences
between the 2 groups at both the 12th week after STZ
injection and the 16th week after STZ injection. However,
at the 12th week after STZ injection, only the Ep/Ap ratio
of the 2 groups reached statistical significance, and Ep of
the 2 groups failed to reach statistical significance in the
conventional flow Doppler of tricuspid annulus. Boyer et
al. confirmed that TDI has a rate of sensitivity of up to 63%
against the 50% of the pulsed Doppler (19).
Collectively, our type 2 diabetic rat model was a good
choice for studying diabetic myocardial disease. Moreover,
this study demonstrated that diastolic dysfunction of
RV was the earliest complication observed in DCM. The
systolic dysfunction of RV was not evident in our study.
As a modern echocardiographic technique, TDI showed

high sensitivity in detecting changes of RV function.
Diabetes is associated with profound changes in cardiac
metabolism, structure, and function. The development
of diabetic myocardial disease is multifactorial. The main
pathophysiological mechanisms that are implicated are
possibly as follows: the deficiency of energy utilization in
myocardial cells, hypertrophy and fibrosis, microvascular
remodeling, homeostatic disorders of calcium, the
abnormal activation of the neurohormonal axis, the
overexpression of the inflammatory process, and oxidative
stress (20–23).
Further studies about the pathological evaluation of
RV in diabetic subjects are necessary. We will follow up
with another study to look for the RV pathological changes
and the probable mechanism causing RV impairment in
diabetic patients. We also plan to evaluate the development
of RV function in patients with type 2 diabetes mellitus,
which will be more helpful for clinical patients. There is a
shortcoming in our study that may limit the interpretation
of the results. No RV systolic dysfunction was found in our
study. Apart from simply observing no obvious systolic
dysfunction, another possible reason for this result was
the lack of appropriate indexes for RV systolic function.
Other indexes for RV systolic function, such as tricuspid
annular plane systolic excursion, will be included in our
future studies.
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